- Home
- EVOK vs SYRS Comparison
EVOK vs SYRS Comparison
Compare EVOK & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- SYRS
- Stock Information
- Founded
- EVOK 2007
- SYRS 2011
- Country
- EVOK United States
- SYRS United States
- Employees
- EVOK N/A
- SYRS N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- EVOK Health Care
- SYRS Health Care
- Exchange
- EVOK Nasdaq
- SYRS Nasdaq
- Market Cap
- EVOK 6.5M
- SYRS 7.1M
- IPO Year
- EVOK 2013
- SYRS 2016
- Fundamental
- Price
- EVOK $4.47
- SYRS $0.20
- Analyst Decision
- EVOK
- SYRS Hold
- Analyst Count
- EVOK 0
- SYRS 5
- Target Price
- EVOK N/A
- SYRS $3.00
- AVG Volume (30 Days)
- EVOK 29.5K
- SYRS 3.2M
- Earning Date
- EVOK 03-13-2025
- SYRS 10-31-2024
- Dividend Yield
- EVOK N/A
- SYRS N/A
- EPS Growth
- EVOK N/A
- SYRS N/A
- EPS
- EVOK N/A
- SYRS N/A
- Revenue
- EVOK $8,617,036.00
- SYRS $386,000.00
- Revenue This Year
- EVOK $97.35
- SYRS N/A
- Revenue Next Year
- EVOK $99.52
- SYRS N/A
- P/E Ratio
- EVOK N/A
- SYRS N/A
- Revenue Growth
- EVOK 100.35
- SYRS N/A
- 52 Week Low
- EVOK $3.54
- SYRS $0.18
- 52 Week High
- EVOK $12.32
- SYRS $7.96
- Technical
- Relative Strength Index (RSI)
- EVOK 47.52
- SYRS 35.88
- Support Level
- EVOK $4.30
- SYRS $0.20
- Resistance Level
- EVOK $4.58
- SYRS $0.25
- Average True Range (ATR)
- EVOK 0.26
- SYRS 0.03
- MACD
- EVOK -0.00
- SYRS 0.02
- Stochastic Oscillator
- EVOK 48.22
- SYRS 5.19
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.